Core Viewpoint - China Life Insurance's stock price has experienced fluctuations, with a recent decline of 2.02%, while the company shows a year-to-date increase of 4.89% in stock price [1][2]. Group 1: Stock Performance - As of November 17, China Life's stock price is 43.25 CNY per share, with a market capitalization of 1,222.448 billion CNY [1]. - The stock has seen a 2.70% decline over the past five trading days, a 1.76% increase over the past 20 days, and a 2.78% increase over the past 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, China Life reported a net profit of 167.804 billion CNY, marking a year-on-year growth of 60.54% [2]. - The company has distributed a total of 226.344 billion CNY in dividends since its A-share listing, with 51.103 billion CNY distributed over the last three years [2]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders has increased to 119,700, a rise of 15.32% from the previous period [2]. - The average number of circulating shares per shareholder is 214,145, which is a decrease of 16.86% compared to the previous period [2].

资金流向方面，主力资金净流出3898.62万元，特大单买入2113.65万元，占比6.82%，卖出4650.52万 元，占比15.01%；大单买入7832.09万元，占比25.29%，卖出9193.84万元，占比29.68%。 中国太保今年以来股价涨7.73%，近5个交易日跌1.39%，近20日跌4.10%，近60日跌10.45%。 资料显示，中国太平洋保险(集团)股份有限公司位于中国上海市黄浦区中山南路1号,香港湾仔港湾道18 号中环广场43楼4301室，成立日期1991年5月13日，上市日期2007年12月25日，公司主营业务涉及本公 司属于综合性保险集团公司,主要通过下属的中国太平洋人寿保险股份有限公司(以下简称"太保寿险")和 中国太平洋财产保险股份有限公司(以下简称"太保产险")为客户提供全面的人寿及财产保险产品和服务, 并通过下属的太平洋资产管理有限责任公司管理和运用保险资金。主营业务收入构成为：财产保险 51.25%，人寿及健康保险46.78%，其他及抵销1.00%，资产管理0.97%。 截至9月30日，中国太保股东户数10.20万，较上期增加16.49%；人均流通股69643股，较上期减少 1 ...

资料显示，恒银金融科技股份有限公司位于天津自贸试验区(空港经济区)西八道30号，成立日期2004年 5月12日，上市日期2017年9月20日，公司主营业务涉及提供以金融自助设备为核心的智慧银行解决方 案。主营业务收入构成为：现金类设备及服务64.30%，非现金类设备及服务18.01%，设备配件类 14.24%，技术服务及其他3.46%。 恒银科技所属申万行业为：计算机-计算机设备-其他计算机设备。所属概念板块包括：小盘、电子商 务、证金汇金、一带一路、雄安新区等。 截至9月30日，恒银科技股东户数5.57万，较上期减少4.35%；人均流通股9343股，较上期增加4.54%。 2025年1月-9月，恒银科技实现营业收入2.65亿元，同比增长3.22%；归母净利润1780.02万元，同比增长 149.72%。 分红方面，恒银科技A股上市后累计派现6511.96万元。近三年，累计派现1561.56万元。 机构持仓方面，截止2025年9月30日，恒银科技十大流通股东中，华宝中证金融科技主题ETF 11月17日，恒银科技盘中下跌2.08%，截至09:54，报11.78元/股，成交1.40亿元，换手率2.24%，总市值 ...

Core Viewpoint - Joyo Co., Ltd. experienced a stock price decline of 2.14% on November 17, with a current price of 11.91 CNY per share and a total market capitalization of 9.088 billion CNY [1] Financial Performance - For the period from January to September 2025, Joyo Co., Ltd. reported a revenue of 5.585 billion CNY, a year-on-year decrease of 9.66%, while the net profit attributable to shareholders increased by 26.03% to 124 million CNY [2] - The company has cumulatively distributed 8.147 billion CNY in dividends since its A-share listing, with 458 million CNY distributed over the past three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders for Joyo Co., Ltd. was 39,800, a decrease of 3.69% from the previous period, with an average of 19,118 circulating shares per shareholder, an increase of 3.29% [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited and Southern CSI 1000 ETF, both of which have reduced their holdings compared to the previous period [3] Stock Market Activity - Joyo Co., Ltd. has seen a stock price increase of 16.64% year-to-date, with a 22.15% increase over the last five trading days and a 26.84% increase over the last twenty days [1] - The company has appeared on the stock market's "Dragon and Tiger List" once this year, with the most recent appearance on November 14 [1]

11月17日，康缘药业盘中下跌2.01%，截至09:49，报16.06元/股，成交9313.95万元，换手率1.01%，总 市值90.93亿元。 资金流向方面，主力资金净流出248.13万元，特大单买入693.95万元，占比7.45%，卖出661.12万元，占 比7.10%；大单买入1504.77万元，占比16.16%，卖出1785.73万元，占比19.17%。 康缘药业所属申万行业为：医药生物-中药Ⅱ-中药Ⅲ。所属概念板块包括：中药、禽流感药物、医药电 商、抗流感、证金汇金等。 截至9月30日，康缘药业股东户数4.05万，较上期增加17.20%；人均流通股13969股，较上期减少 14.68%。2025年1月-9月，康缘药业实现营业收入23.43亿元，同比减少24.66%；归母净利润2.00亿元， 同比减少44.10%。 康缘药业今年以来股价涨17.91%，近5个交易日涨1.90%，近20日涨3.81%，近60日跌9.01%。 资料显示，江苏康缘药业股份有限公司位于江苏省连云港市经济技术开发区江宁工业城，成立日期1996 年5月8日，上市日期2002年9月18日，公司主营业务涉及涉及药品的研发、生产与销售。 ...

Core Viewpoint - Guosen Securities experienced a decline of 2.06% in stock price on November 14, with a trading volume of 5.08 billion yuan and a total market capitalization of 141.336 billion yuan [1] Financial Performance - As of September 30, Guosen Securities reported a net profit of 9.137 billion yuan, representing a year-on-year growth of 87.28% [2] - The company has distributed a total of 27.626 billion yuan in dividends since its A-share listing, with 8.555 billion yuan distributed in the last three years [3] Stockholder Information - The number of shareholders increased by 14.52% to 111,100 as of September 30, while the average circulating shares per person decreased by 8.16% to 86,530 shares [2] - Major shareholders include Hong Kong Central Clearing Limited, which holds 136 million shares, a decrease of 27.7725 million shares from the previous period [3] Market Activity - The stock price of Guosen Securities has increased by 27.19% year-to-date, but has seen a decline of 2.54% over the last five trading days [1] - The company’s main business revenue composition includes 49.18% from investment and trading, 47.09% from wealth management and institutional business, 3.37% from investment banking, and 3.05% from asset management [1]

Core Viewpoint - Luzhou Laojiao's stock price has experienced fluctuations, with a current decline of 2.00% and a market capitalization of 206.736 billion yuan, reflecting a mixed performance in recent trading sessions [1] Financial Performance - For the period from January to September 2025, Luzhou Laojiao reported operating revenue of 23.127 billion yuan, a year-on-year decrease of 4.84%, and a net profit attributable to shareholders of 10.762 billion yuan, down 7.17% year-on-year [2] - The company has distributed a total of 52.059 billion yuan in dividends since its A-share listing, with 22.926 billion yuan distributed over the past three years [2] Stockholder Information - As of September 30, 2025, the number of shareholders for Luzhou Laojiao decreased by 22.54% to 161,200, while the average number of circulating shares per person increased by 29.13% to 9,114 shares [2] - The top ten circulating shareholders include notable entities such as the China Securities Finance Corporation and various ETFs, with changes in their holdings indicating shifts in institutional interest [3]

11月14日，黑牡丹（维权）盘中下跌2.00%，截至13:00，报9.79元/股，成交1.01亿元，换手率0.99%， 总市值101.04亿元。 机构持仓方面，截止2025年9月30日，黑牡丹十大流通股东中，南方中证房地产ETF发起联接A （004642）位居第五大流通股东，持股653.16万股，相比上期减少3.82万股。香港中央结算有限公司位 居第七大流通股东，持股639.80万股，相比上期减少83.00万股。 责任编辑：小浪快报 黑牡丹所属申万行业为：房地产-房地产开发-住宅开发。所属概念板块包括：土地流转、江苏国资、证 金汇金、破净股、PPP概念等。 截至9月30日，黑牡丹股东户数2.78万，较上期减少13.97%；人均流通股37136股，较上期增加16.24%。 2025年1月-9月，黑牡丹实现营业收入24.43亿元，同比增长34.79%；归母净利润6379.21万元，同比减少 19.62%。 分红方面，黑牡丹A股上市后累计派现27.20亿元。近三年，累计派现3.91亿元。 资金流向方面，主力资金净流出539.58万元，特大单买入398.72万元，占比3.93%，卖出1033.65万元， 占比10.1 ...

Group 1 - The core viewpoint of the news is that Industrial Bank's stock has shown a positive trend, with a 19.94% increase in price year-to-date and a recent rise of 2.55% over the last five trading days [1] - As of November 14, the stock price reached 21.71 CNY per share, with a market capitalization of 459.446 billion CNY and a trading volume of 1.321 billion CNY [1] - The net inflow of main funds was 7.7979 million CNY, with significant buying and selling activity from large orders [1] Group 2 - As of September 30, the number of shareholders increased by 13.93% to 217,900, while the average circulating shares per person decreased by 12.22% to 97,121 shares [2] - For the period from January to September 2025, Industrial Bank reported a net profit of 63.083 billion CNY, reflecting a year-on-year growth of 0.12% [2] - The bank has distributed a total of 216.103 billion CNY in dividends since its A-share listing, with 68.718 billion CNY distributed over the past three years [2]

Core Viewpoint - The stock of Jia Shitang has shown a significant increase in price and trading activity, indicating potential investor interest despite recent declines in revenue and profit [1][2]. Group 1: Stock Performance - On November 14, Jia Shitang's stock rose by 2.01%, reaching 15.71 CNY per share, with a trading volume of 93.48 million CNY and a turnover rate of 2.06%, resulting in a total market capitalization of 4.583 billion CNY [1]. - Year-to-date, Jia Shitang's stock price has increased by 23.22%, with a 7.02% rise over the last five trading days, 16.20% over the last 20 days, and 8.27% over the last 60 days [1]. - The company has appeared on the "Dragon and Tiger List" once this year, with the most recent appearance on May 8, where it recorded a net buy of -534.52 million CNY [1]. Group 2: Financial Performance - For the period from January to September 2025, Jia Shitang reported operating revenue of 14.459 billion CNY, a year-on-year decrease of 21.80%, and a net profit attributable to shareholders of 141 million CNY, down 38.81% year-on-year [2]. - Cumulatively, Jia Shitang has distributed 874 million CNY in dividends since its A-share listing, with 216 million CNY distributed over the past three years [3]. Group 3: Company Overview - Jia Shitang Pharmaceutical Co., Ltd. is located in Haidian District, Beijing, and was established on April 22, 1997, with its shares listed on August 18, 2010. The company's main business involves pharmaceutical wholesale and retail [1]. - The company operates in the pharmaceutical and biological sector, specifically in pharmaceutical commerce and distribution, and is involved in various concept sectors including small-cap stocks, pharmaceutical e-commerce, and cold chain logistics [2].